1. 'Click chemistry' for diagnosis: a patent review on exploitation of its emerging trends. (December 2014) Authors: Mandhare, Anita; Banerjee, Paromita; Bhutkar, Smita; Hirwani, Rajkumar Journal: Expert opinion on therapeutic patents Issue: Volume 24:Number 12(2014:Dec.) Page Start: 1287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 'Raising the bar' of patentability. (March 2012) Authors: Atkinson, Jonathan; Jones, Rachel Journal: Pharmaceutical patent analyst Issue: Volume 1:Number 1(2013) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 'Reference composition' not 'lead compound': recent developments in case law for obviousness of pharmaceutical composition claims. (September 2012) Authors: Highlander, Steven L; Voges, Mark H Journal: Pharmaceutical patent analyst Issue: Volume 1:Number 4(2013) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1, 2-Benzisoxazole compounds: a patent review (2009 – 2014). (June 2015) Authors: Uto, Yoshikazu Journal: Expert opinion on therapeutic patents Issue: Volume 25:Number 6(2015:Jun.) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1, 3-Oxazines as BACE1 and/or BACE2 inhibitors: a patent evaluation (WO2012156284). (August 2013) Authors: Gilbert, Eric J Journal: Expert opinion on therapeutic patents Issue: Volume 23:Number 8(2013:Aug.) Page Start: 1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 10 years after implementation of TRIPS obligations in India. (May 2015) Authors: Pawar, Mahesh D Journal: Pharmaceutical patent analyst Issue: Volume 4:Number 3(2015) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 15-Lipoxygenase inhibitors: a patent review. (2nd January 2016) Authors: Sadeghian, Hamid; Jabbari, Atena Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 1(2016:Jan.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2, 2, 2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927. (1st December 2016) Authors: Dotsenko, Victor V.; Chigorina, Elena A.; Krivokolysko, Sergey G. Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 12(2016:Dec.) Page Start: 1371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014). (1st February 2016) Authors: Leoni, Alberto; Locatelli, Alessandra; Morigi, Rita; Rambaldi, Mirella Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 2(2016:Feb.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase modulator: toward age- and sex-personalized medicine. (3rd October 2015) Authors: Pallottini, Valentina Journal: Expert opinion on therapeutic patents Issue: Volume 25:Number 10(2015:Oct.) Page Start: 1079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗